Skip to main content
logo
Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
27.86
+0.25 (0.91%)
At close: Mar 16, 2026, 4:00 PM EDT
28.10
+0.24 (0.86%)
After-hours: Mar 16, 2026, 7:34 PM EDT

HRMY Revenue

In the year 2025, Harmony Biosciences Holdings had annual revenue of $868.45M with 21.51% growth. Harmony Biosciences Holdings had revenue of $243.78M in the quarter ending December 31, 2025, with 21.12% growth.

Revenue (ttm)
$868.45M
Revenue Growth
+21.51%
P/S Ratio
1.86
Revenue / Employee
$2,964,003
Employees
293
Market Cap
1.61B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025868.45M153.72M21.51%
Dec 31, 2024714.73M132.71M22.80%
Dec 31, 2023582.02M144.17M32.93%
Dec 31, 2022437.86M132.42M43.35%
Dec 31, 2021305.44M145.70M91.21%
Dec 31, 2020159.74M153.75M2,564.59%
Dec 31, 20196.00M--
Dec 31, 2018---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Novavax1.12B
Innoviva411.33M
Immunocore Holdings400.02M
Vericel276.26M
Iovance Biotherapeutics263.50M
Nurix Therapeutics83.98M
Nuvation Bio62.90M
Agios Pharmaceuticals54.03M
Revenue Rankings

HRMY News

More News